Pharmaceutical innovation for neurological diseases
We reposition drugs such as rimonabant to improve the lives of patients with spinal cord damage, ictus and other pathologies of the central nervous system.
About Sinfatin
In Sinfatin SL We believe in a new way of approaching the treatment of central nervous system pathologies.
We bet on the Pharmaceutical innovation for neurological diseases Through the repositioning of existing drugs, which allows us to reduce development times and offer safer and more effective solutions.
We have a team of physicians, biologists, and professionals with solid clinical and scientific experience, committed to a common goal: improve the quality of life of people living with spinal cord injury, stroke, and other neurological diseases through accessible and innovative treatments.
Therapeutic areas
At Sinfatin we work to offer real solutions to patients with diseases of the central nervous systemOur commitment is based on the research and development of innovative treatments through the repositioning of drugs
Spinal cord damage
We are investigating new therapeutic applications that help restore lost functions and slow the progression of damage.
Ictus
We evaluated the potential of rimonabant in improving post-stroke recovery.
Other neurological diseases
We continue to expand our therapeutic reach with ongoing research projects.
Rimonabant: Our main project
We are currently leading a clinical development program with rimonabant, a selective inhibitor of endocannabinoid receptors in the central nervous system.
This medicine, with an already known safety profile, is being evaluated in clinical trials for the treatment of neurological diseases with a major impact on patients' quality of life.
Chemical structure of SR141716A (Rimonabant)
Direct contact
Are you a patient, healthcare professional, or investor?
We are here to help you. Write to us and we will respond as soon as possible.
We work to improve the lives of those living with neurological disorders.
From the clinical development of rimonabant to supporting patients, healthcare professionals, and investors, our commitment is to advancing more effective, safe, and accessible treatments.
